InterAx

InterAx
AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.
About
What does InterAx do?
InterAx Biotech develops novel therapies by translating complex biology into breakthrough medicines using its Deep Signal™ platform. This platform integrates mathematical modeling, experimental methods, and machine learning to decipher cell signaling language, enabling the design of highly efficacious small molecule drug candidates targeting GPCRs. InterAx serves to generate high-efficacy leads and improve drug profiles by understanding disease impact before pre-clinical trials.
What is InterAx's revenue?
StartupHub estimates InterAx's annual revenue at $945K (range $525K to $2.2M, 63% confidence), based on comparable companies in the sector.
What is InterAx's valuation?
StartupHub estimates InterAx's effective valuation at $10.6M (range $6.8M to $16.2M, 10% confidence), based on comparable companies in the sector.
How much funding has InterAx raised?
InterAx has raised a total of $3M in funding. The most recent round on record is Funding Round.
Where is InterAx headquartered?
InterAx is headquartered in Schlieren, Switzerland.
When was InterAx founded?
InterAx was founded in 2016.
What industry does InterAx operate in?
InterAx operates in Biotech, Drug Discovery, AI, Computational Pharmacology, GPCR, Platform.
How many employees does InterAx have?
InterAx has approximately 15 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.